Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma

Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma

Ting Ye,1,2 Li Fan,1 Rubo Cao,1 Ling Peng,1 Jing Chen1,3 1Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China; 2Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, 430022, People’s Republic of China;...

Full description

Saved in:
Bibliographic Details
Main Authors: Ye T, Fan L, Cao R, Peng L, Chen J
Format: Article
Language:English
Published: Dove Medical Press 2025-08-01
Series:Drug Design, Development and Therapy
Subjects:
soft tissue sarcomas
pegylated liposomal doxorubicin
ifosfamide
dose-escalation
safety
Online Access:https://www.dovepress.com/phase-i-trial-of-pegylated-liposomal-doxorubicin-combined-with-ifosfam-peer-reviewed-fulltext-article-DDDT
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/phase-i-trial-of-pegylated-liposomal-doxorubicin-combined-with-ifosfam-peer-reviewed-fulltext-article-DDDT

Similar Items